How good are we at picking up depressing in RA patients? In this Polish registry: - 1.8% had a depression diagnosis - 21% had low mood on HAQ & depression has real correlates with disease activity. Plenty to think about with truly holistic RA care! #EULAR2024 POS1045 @RheumNow https://t.co/ZNbMVo8TGk

Just a reminder - large vessel involvement is very common in GCA, and lines up with aortic dilatation. And if you don’t look, you won’t find… #EULAR2024 POS0932 @RheumNow https://t.co/2uZTu0B18Z

Bold conclusion from Japan: laughter improves function in RA. I like it Feel like it might be partially a correlation/causation link but if an hour of laughter can push down IL-6 levels in RA patients, time for reimbursement for stand up comedy? #EULAR2024 POS1029 @RheumNow https://t.co/EpHnX50PgF

Interpreting Hepatis B serology results. Hyrich K #EULAR2024 @RheumNow https://t.co/boXw2XCI2m

Approach to TB screening prior to commencing biologics. Hyrich K #EULAR2024 @RheumNow https://t.co/j3PI0PHpqW

New imaging technique PET/CT imaging with 68Gallium-labelled Fibroblast Activation Protein Inhibitor-04 (68Ga-FAPI-04) enables the visualization of fibroblast activation in vivo. No correlations with MSUS findings were found. Fibroblast activation detected by 68Ga-FAPI-04-PET/CT… https://t.co/4VTF1YDzYd https://t.co/Y8Hmlf3sWl

Cycle or swap 2? Post failure to a first TNFi in patients with PsA, there was no difference in cycle versus swap to IL17i for drug retention rate or disease activity. In male PsA patients a cycle strategy had a longer drug retention rate compared to a swap (IL-17i) strategy.… https://t.co/5BykvDwFWV https://t.co/GfcnIltV2A

Prof Hellmich takes us through “What is new?” In ANCA #vasculitis A tour de force in management strategies and, continuing a theme of #EULAR2024, ends with a study suggesting the potential of #CAR-T! @RheumNow https://t.co/K3dDqZhUvD

What is better for #Rx of #osteoporosis? #Denosumab or ##Zoledronic acid? #Prolia compared to #Aclasta Giant admin US data of 125,000 Rx niaive women with #OP ▶️Prolia has LESS fractures! POS0583 #EULAR2024 @eular_org @RheumNow https://t.co/eo1ny2VIRf

✨ Delighted to be chairing the session on newly diagnosed #RMDs in the PARE programme this afternoon, featuring a fantastic panel of speakers! 👥 Perfect for patients and clinicians alike! 👇🏼 All details below- hope to see you there @RheumNow #EULAR2024 https://t.co/8RmcH8qprJ

What is better in #PsA #psoriatic #arthritis #TNFi or #apremilast #PDE4i #COREVITAS database study in #PsA YOU can guess the answer! 1st line advanced RxTNFi lasts longer - retention Vs PDE4i #EULAR2024 @RheumNow @eular_org POS0990 https://t.co/VmYG6Rj87c

Cycle or Swap? The swap strategy (SG) (i.e. from TNFi to IL17i) had higher retention rates compared to the change strategy (CG) choice in PsA patients who failed the first line of advanced treatment. The 5 years retention rate in SG was higher than in CG (57,8% vs 45,2%; p=0.1).… https://t.co/pH5rFI00vK https://t.co/XqTHO1tIr3